DBV Technologies SA is a biopharmaceutical company. It is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:DBV.
$6.43 +0.54 (9.17%)
As of 04/14/2021 15:59:30 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.